Panelists at Rare Disease Day at NIH
Panelists from Session 3: “Success Factors for Rare Cancer Research — Building Strong Foundations” during Rare Disease Day at NIH on Feb. 28, 2019 (left to right): Corrie Painter, Ph.D., of Count Me In, the Massachusetts Institute of Technology and Harvard University; Jim Palma of TargetCancer Foundation and of the Rare Cancer Coalition at the National Organization for Rare Disorders; Jack J. Welch, M.D., Ph.D., of the International Rare Cancer Initiative at the National Cancer Institute (NCI); Denise Reinke, M.S., N.P., M.B.A., of the Sarcoma Alliance for Research Through Collaboration; Karlyne M. Reilly, Ph.D., of the Rare Tumor Initiative at NCI; and moderator Abby B. Sandler, Ph.D., of the My Pediatric and Adult Rare Tumor (MyPART) Network at NCI.
Credit: Daniel Soñé Photography
Panelists at Rare Disease Day at NIH
Panelists from Session 3: “Success Factors for Rare Cancer Research — Building Strong Foundations” during Rare Disease Day at NIH on Feb. 28, 2019 (left to right): Corrie Painter, Ph.D., of Count Me In, the Massachusetts Institute of Technology and Harvard University; Jim Palma of TargetCancer Foundation and of the Rare Cancer Coalition at the National Organization for Rare Disorders; Jack J. Welch, M.D., Ph.D., of the International Rare Cancer Initiative at the National Cancer Institute (NCI); Denise Reinke, M.S., N.P., M.B.A., of the Sarcoma Alliance for Research Through Collaboration; Karlyne M. Reilly, Ph.D., of the Rare Tumor Initiative at NCI; and moderator Abby B. Sandler, Ph.D., of the My Pediatric and Adult Rare Tumor (MyPART) Network at NCI.
Credit: Daniel Soñé Photography